Operating Segments (Tables)

3 Months Ended

Mar. 31, 2022

Operating Segments

Schedule of operating segments

	Three Months Ended
	March 31,
	2022		2021
Revenues
Specialized BioTherapeutics	$	—	$	—
Public Health Solutions		188,063		147,593
Total	$	188,063	$	147,593
Loss from Operations
Specialized BioTherapeutics	$	(1,539,728)	$	(1,112,408)
Public Health Solutions		(120,621)		(130,781)
Corporate		(2,542,279)		(990,418)
Total	$	(4,202,628)	$	(2,233,607)
Amortization and Depreciation Expense
Specialized BioTherapeutics	$	2,614	$	1,899
Public Health Solutions		436		316
Corporate		5,182		6,684
Total	$	8,232	$	8,899
Other (Expense)/Income, Net
Specialized BioTherapeutics	$	55,079	$	84,634
Corporate		(201,472)		(213,505)
Total	$	(146,393)	$	(128,871)
Share-Based Compensation
Specialized BioTherapeutics	$	28,504	$	29,579
Public Health Solutions		1,054		6,295
Corporate		48,713		58,931
Total	$	78,271	$	94,805

	As of		As of
	March 31,		December 31,
	2022		2021
Identifiable Assets
Specialized BioTherapeutics	$	223,895	$	128,645
Public Health Solutions		132,921		146,296
Corporate		23,317,828		26,594,986
Total	$	23,674,644	$	26,869,927